Conversely, NCR3LG1 has primarily been associated with various cancer types [53, 54], while RP1-239B22.5 has received minimal research attention—only one study to date has reported elevated expression in late-stage cancer [55]. This evidence concerns the gene NCR3LG1 and cancer.